Comparison of Physiotherapy Versus Home Exercise Following Hip Replacement Surgery
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00175448|
Recruitment Status : Completed
First Posted : September 15, 2005
Last Update Posted : September 25, 2008
|Condition or disease||Intervention/treatment|
|Arthritis Arthroscopic Hip Surgery||Procedure: physiotherapy|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||144 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||A Randomized Controlled Trial of Outpatient Physiotherapy Versus a Self-Administered Home Exercise Program Following Discharge Home From Total Hip Arthroplasty|
|Study Start Date :||September 2005|
|Primary Completion Date :||December 2007|
|Study Completion Date :||December 2007|
- Physical function at 16 weeks post THA in patients who received outpatient physiotherapy following discharge home compared to unsupervised self- directed exercises alone (as measured by the WOMAC). [ Time Frame: 16 weeks ]
- Does outpatient physiotherapy result in superior outcomes (final outcome) at 1 and 2 years post THA? [ Time Frame: 2 years ]
- Does outpatient physiotherapy, compared to a self-directed exercise program, result in greater improvement in:
- generic health-related QOL (SF-36) and (HUI3)
- pain and stiffness (WOMAC pain and stiffness)
- activities of daily living (FSI)
- patient satisfaction (Brigham and Women's patient satisfaction)
- objective physical function (TUG, Harris Hip, Gait Lab)
- What is the marginal cost effectiveness of outpatient physiotherapy versus self-directed exercises?
- How does the recovery over time compare between programs (trajectory of recovery) ?
- What is the difference in musculoskeletal adverse event rate (ie dislocation)?
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00175448
|Principal Investigator:||Nelson Greidanus, MD||University of British Columbia|